A detailed history of Resonant Capital Advisors, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Resonant Capital Advisors, LLC holds 4,345 shares of BSX stock, worth $457,311. This represents 0.03% of its overall portfolio holdings.

Number of Shares
4,345
Previous 3,987 8.98%
Holding current value
$457,311
Previous $334,000 16.17%
% of portfolio
0.03%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 24, 2025

BUY
$83.62 - $91.5 $29,935 - $32,757
358 Added 8.98%
4,345 $388,000
Q3 2024

Oct 18, 2024

BUY
$72.96 - $84.0 $15,029 - $17,304
206 Added 5.45%
3,987 $334,000
Q2 2024

Aug 01, 2024

BUY
$67.33 - $77.71 $32,587 - $37,611
484 Added 14.68%
3,781 $291,000
Q1 2024

May 01, 2024

BUY
$57.6 - $68.62 $189,907 - $226,240
3,297 New
3,297 $225,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $151B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Resonant Capital Advisors, LLC Portfolio

Follow Resonant Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resonant Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Resonant Capital Advisors, LLC with notifications on news.